Abrdn World Healthcare Fund (THW)

The most critical observation is the severe multi-year structural decline: the asset has lost over 25% of its value since 2016, with four consecutive years of negative annual returns ending in a sharp 12.33% drop last year. This persistent downward trajectory, despite a low P/E ratio, indicates that the market views the underlying business quality as deteriorating rather than undervalued. While the recent price action shows a modest bounce off the lows, the momentum remains fragile given the heavy weight of the prior declines. The dividend yield appears attractive at 10%, but this is largely a mathematical artifact of the falling share price; the payout ratio sits at 66%, suggesting the distribution is consuming a significant portion of earnings without providing a true income safety margin. Consequently, the investment case is weak on both capital appreciation and sustainable income.